益方生物：预计2025年度净利润亏损3.17亿元

Group 1 - The company expects to achieve operating revenue of 37.3253 million yuan in 2025, with a net profit attributable to the parent company of -317 million yuan [1] - The reported financial data is preliminary and has not been audited by an accounting firm [1] - The performance changes in 2025 are primarily influenced by the intensity of research and development investment and the composition of revenue [1]